Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Back to Blog
Genomics

Your 23andMe Results Could Unlock Personalized Clinical Trials

Crick Team
February 15, 2026
6 min read
23andMeGeneticsPrivacyPersonalized Medicine

Your 23andMe Results Could Unlock Personalized Clinical Trials

You paid $99 for that 23andMe test. You got some interesting ancestry results—turns out you're 2% Neanderthal, your ancestors came from unexpected places, and you're genetically predisposed to hate cilantro. Fun facts for dinner parties.

But that raw genetic data file sitting in your 23andMe account contains something far more valuable: information about clinically significant variants that could connect you to cutting-edge clinical trials and help you understand your disease risks.

Most people download their raw data once, glance at the cryptic file full of rsIDs and genotypes, and never look at it again. It's like buying a treasure map, reading the pretty parts, and using it as a coaster.

Crick's 23andMe Genome Analyzer unlocks that treasure. And it does so while keeping your genetic data completely private—processed entirely in your browser, never touching our servers, never leaving your device.

What's Actually in Your Raw Data File

When you download your raw genetic data from 23andMe, you get a text file with hundreds of thousands of entries that look like this:

rs429358    19    45411941    CC
rs7412      19    45412079    CT
rs1801133   1     11856378    AG

Each line represents a Single Nucleotide Polymorphism (SNP)—a position in your genome where humans vary. The first column is an identifier (like rs429358), the next columns tell you where in the genome it is, and the last column tells you which variants you have (like CC, CT, or AG).

Some of these SNPs are meaningless—they don't affect anything we know about. Others are incredibly significant.

For example:

  • rs429358 and rs7412 together determine your APOE genotype, which affects Alzheimer's disease risk
  • rs1801133 in the MTHFR gene affects how you process folate, relevant to cardiovascular health and pregnancy
  • rs1799971 in the OPRM1 gene affects opioid response—some people need higher doses for pain management
  • rs4988235 determines if you're lactose tolerant as an adult

23andMe shows you some of this in their health reports (if you paid for that tier). But they're limited by FDA regulations on what they can tell you, and they certainly don't connect your variants to clinical trials.

That's where Crick comes in.

How Crick's Genome Analyzer Works

Upload your 23andMe raw data file to Crick, and here's what happens:

Step 1: Client-Side Parsing The file is parsed entirely in your browser using JavaScript Web Workers. This isn't marketing speak—your data genuinely never leaves your device. We can't see it, can't store it, don't have access to it. The entire analysis runs locally on your computer.

Why does this matter? Because genetic data is the most personal information you have. It reveals not just information about you, but about your biological relatives. Privacy isn't a feature—it's a fundamental requirement.

Step 2: Variant Annotation Crick cross-references your SNPs against ClinVar (NIH's database of genetic variants and their clinical significance) and OpenTargets (gene-disease associations). For each variant you carry, we check:

  • Is it classified as pathogenic, likely pathogenic, benign, or uncertain?
  • What genes does it affect?
  • What diseases is it associated with?
  • What drugs might be affected (pharmacogenomics)?
  • Are there clinical trials recruiting patients with this variant?

Step 3: Knowledge Graph Integration The really powerful part: your variants are integrated into Crick's Knowledge Graph. You can see your genetic profile as nodes in the network, connected to:

  • Genes carrying variants
  • Diseases you may be at risk for
  • Drugs that might work differently for you
  • Clinical trials recruiting your specific genotype

Step 4: Actionable Insights The analyzer generates a report highlighting:

  • Clinically significant variants (especially pathogenic ones)
  • Disease risk associations backed by strong evidence
  • Pharmacogenomic findings (drug-gene interactions)
  • Relevant clinical trials

Real Examples: What You Might Discover

Example 1: BRCA Mutations and Cancer Trials

Sarah ran her 23andMe data through Crick and discovered she carries a pathogenic variant in BRCA2 (specifically rs80359550). This variant significantly increases lifetime risk of breast and ovarian cancer.

What Crick showed her:

  • The specific variant and its ClinVar classification
  • A link to the BRCA2 gene page, showing all BRCA2-associated diseases
  • Clinical trials recruiting BRCA2-positive individuals for:
    • Preventive strategies (PARP inhibitor chemoprevention)
    • Enhanced screening protocols
    • Risk-reducing surgical trials
  • Drugs that specifically target BRCA-deficient cancers (PARP inhibitors like Olaparib)

Sarah hadn't been diagnosed with cancer, but knowing her genetic risk allowed her to:

  • Start enhanced screening (earlier and more frequent)
  • Consider preventive options
  • Make informed family planning decisions
  • Pre-emptively identify trials she'd be eligible for if diagnosed

Example 2: Pharmacogenomics and Drug Response

Marcus uploaded his data and found he carries two copies of a variant in CYP2C19 (a poor metabolizer genotype). This gene codes for an enzyme that metabolizes many common drugs, including:

  • Clopidogrel (blood thinner used after heart attacks and stents)
  • Many antidepressants (SSRIs)
  • Proton pump inhibitors for acid reflux

For someone with Marcus's genotype, standard doses of clopidogrel don't work well—the drug isn't activated properly. If Marcus ever needed a stent, this information is literally life-saving. His cardiologist would need to use an alternative drug.

Crick also connected Marcus to:

  • Clinical trials testing alternative antiplatelet therapies
  • Studies on genotype-guided drug dosing
  • Research on CYP2C19 and cardiovascular outcomes

Example 3: Rare Disease Diagnosis

Emily's son had been experiencing unexplained developmental delays. Doctors ran standard tests but found nothing conclusive. Emily uploaded his 23andMe data (yes, 23andMe works for kids' data too) and found a rare variant in a gene associated with a metabolic disorder.

This wasn't a diagnosis—23andMe doesn't test comprehensively enough for that—but it was a lead. Emily shared the finding with her son's neurologist, who ordered targeted genetic testing that confirmed the condition.

Crick then connected them to:

  • The only two clinical trials globally for this rare condition
  • Support groups and research foundations
  • Experimental therapies in development

Without Crick, they might never have made the connection. The condition was too rare to be on the diagnostic checklist.

Example 4: Alzheimer's Risk and Prevention Trials

Robert learned he's APOE4/E4 (two copies of the E4 variant), putting him at significantly elevated risk for Alzheimer's disease. This is one of the strongest genetic risk factors for late-onset Alzheimer's.

What Crick showed him:

  • His specific genotype and what it means for risk
  • Current evidence on APOE4 and Alzheimer's
  • Prevention trials recruiting APOE4 carriers before they develop symptoms:
    • Lifestyle intervention studies
    • Preventive drug trials
    • Cognitive training programs
  • Research on APOE4 and response to different treatments

Robert enrolled in a prevention trial testing whether a specific lifestyle intervention (diet, exercise, cognitive training) could delay Alzheimer's onset in high-risk individuals. He's essentially getting early intervention years before any symptoms.

What About Accuracy and Limitations?

Let's be clear about what 23andMe data is and isn't:

What it IS:

  • A snapshot of ~700,000 common genetic variants
  • Accurate for the variants it tests (>99% genotyping accuracy)
  • Useful for finding clinically significant variants you carry
  • Great for pharmacogenomics and common disease risk

What it ISN'T:

  • Comprehensive clinical-grade sequencing (that tests millions of variants)
  • A substitute for diagnostic testing ordered by a doctor
  • Able to detect all genetic causes of disease (many rare variants aren't tested)
  • Definitive—variants of uncertain significance are just that: uncertain

If Crick's analyzer flags a pathogenic variant, especially for a serious condition, you should:

  1. Discuss with a doctor or genetic counselor
  2. Consider confirmatory clinical testing (often covered by insurance if medically indicated)
  3. Not panic—genetic risk isn't destiny; many factors influence disease

Privacy: Why Browser-Based Processing Matters

You might think: "Why does it matter if Crick sees my data? I trust them."

Even if you trust us (thank you!), here's why client-side processing is important:

No data breach risk: We can't leak data we never received. Companies with the best security still get hacked. The only unbreakable security is not storing sensitive data in the first place.

No terms of service changes: We can't change our privacy policy to monetize your genetic data later, because we never had it.

No subpoenas: We can't be compelled to hand over your genetic data to law enforcement, insurance companies, or anyone else, because we don't have it.

No future risk: Even if Crick gets acquired by a company with different values, or goes out of business, or decides to pivot to selling genetic data (we won't, but theoretically), your data was never exposed.

This isn't theoretical paranoia. GEDmatch, a genetic genealogy site, had its database searched by law enforcement. 23andMe has received subpoenas for customer data. Genetic information is powerful and sensitive.

Crick's approach eliminates the risk entirely.

How to Use the Genome Analyzer

  1. Download your raw data from 23andMe:

    • Log into 23andMe
    • Go to Account → Settings → Download Raw Data
    • Wait for the file (they email it, usually within 24 hours)
    • You'll get a zip file with a .txt file inside
  2. Upload to Crick:

    • Go to crick.ai/genome
    • Click "Upload 23andMe Data"
    • Select your raw data file
    • Processing takes 30-60 seconds (all in your browser)
  3. Explore results:

    • Browse clinically significant variants
    • Click any variant to see it in the Knowledge Graph
    • Filter by disease category or gene
    • Export a PDF report to share with your doctor
  4. Find relevant trials:

    • Click "Show Clinical Trials" for any variant
    • Filter by location, phase, recruitment status
    • Save trials of interest
  5. Optional: Save your analysis:

    • Crick can store an encrypted version of your analysis (not your raw data) if you create an account
    • This is optional and uses local browser storage
    • Your raw genetic data still never touches our servers

Beyond 23andMe: Other Data Sources

While Crick's analyzer is optimized for 23andMe, it also works with:

  • AncestryDNA raw data (similar format)
  • MyHeritage DNA raw data
  • Nebula Genomics (more comprehensive, 30x whole genome)

The more comprehensive your data, the more insights Crick can provide. But 23andMe's 700,000 SNPs cover most clinically actionable variants.

The Future: Whole Genome Sequencing

Direct-to-consumer whole genome sequencing is becoming affordable ($200-$500). Companies like Nebula, Dante Labs, and Sequencing.com offer it. Whole genome sequencing tests millions of variants instead of 700,000, catching rare variants that 23andMe misses.

Crick is building support for whole genome VCF files (the standard format for sequence data). Imagine uploading your entire genome and seeing:

  • Every pathogenic variant you carry
  • Rare disease genes with mutations
  • Novel variants of uncertain significance
  • Comprehensive pharmacogenomic profile
  • Connection to every relevant clinical trial

This is precision medicine at the individual level—your genome connected to the world's medical knowledge.

Ethical Considerations

With great genetic knowledge comes responsibility. Some findings are difficult:

  • Learning you have increased Alzheimer's risk with no proven prevention
  • Discovering carrier status for recessive diseases
  • Finding out about adult-onset conditions your children might inherit
  • Uncovering unexpected family relationships (non-paternity events)

Before uploading your data, consider:

  • Do you want to know everything, or just actionable findings?
  • How will you handle uncertain results?
  • Should you discuss with family members first?
  • Do you have access to genetic counseling if needed?

Crick provides information, but information has psychological impact. We're building features to let you control what you see—choose to view only actionable findings, only certain disease categories, etc.

Genetic knowledge is powerful. Use it wisely.

Your DNA, Your Decisions

You paid for that 23andMe test. The data is yours. It's sitting in a file on 23andMe's servers or in your downloads folder, full of information that could:

  • Connect you to clinical trials you didn't know existed
  • Reveal drug interactions your doctor hasn't considered
  • Identify disease risks you can act on
  • Contribute to research (if you choose)

Crick gives you the tools to unlock that information—privately, securely, and connected to the world's largest clinical trial database.

Your genetic data doesn't have to be a curiosity. It can be a compass, pointing you toward trials, treatments, and insights that could change your life.

Download your data. Upload to Crick. Discover what your genetics reveal.


Analyze your 23andMe data at crick.ai/genome

Explore More Insights

Discover more articles about precision medicine and biomedical research.

View All Posts